These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 38402500
1. Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020. Sasaki S, Shimizu S, Nakaya I, Miyaoka Y, Koizumi M, Nishiwaki H, Sofue T, Ishimoto T, Kurita N, Wada T. Clin Exp Nephrol; 2024 Jun; 28(6):531-538. PubMed ID: 38402500 [Abstract] [Full Text] [Related]
2. The Sensitivity and Specificity of Serum Phospholipase A2 Receptor Antibodies in Diagnosing Primary Membranous Nephropathy in Patients with Adult Nephrotic Syndrome and its Correlation with Serum Phospholipase A2 Receptor Staining in Kidney Biopsies. Vellakampadi D, Bonu R, Siddini V, Vankalakunti M. Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):416-426. PubMed ID: 38995300 [Abstract] [Full Text] [Related]
3. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V. Nephrology (Carlton); 2015 Aug 01; 20(8):572-5. PubMed ID: 26194981 [Abstract] [Full Text] [Related]
4. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC. Kidney Int; 2019 Feb 01; 95(2):429-438. PubMed ID: 30665573 [Abstract] [Full Text] [Related]
10. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Zhao Y, Cai M, Jiang Z, Dong B, Yan Y, Wang Y, Zuo L. Ren Fail; 2022 Dec 01; 44(1):428-433. PubMed ID: 35272568 [Abstract] [Full Text] [Related]
13. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy. Stefan G, Stancu S, Zugravu A, Popa O, Zubidat D, Petre N, Mircescu G. Ren Fail; 2022 Dec 07; 44(1):258-268. PubMed ID: 35172682 [Abstract] [Full Text] [Related]
14. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy. Quintana LF, Blasco M, Seras M, Pérez NS, López-Hoyos M, Villarroel P, Rodrigo E, Viñas O, Ercilla G, Diekmann F, Gómez-Roman JJ, Fernandez-Fresnedo G, Oppenheimer F, Arias M, Campistol JM. Transplantation; 2015 Aug 07; 99(8):1709-14. PubMed ID: 25675198 [Abstract] [Full Text] [Related]
16. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S. Clin Exp Nephrol; 2015 Aug 07; 19(4):653-60. PubMed ID: 25412738 [Abstract] [Full Text] [Related]
17. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy. Teisseyre M, Perrochia H, Reboul P, Cariou S, Renaud S, Aglae C, Moranne O. BMC Nephrol; 2020 May 24; 21(1):196. PubMed ID: 32448215 [Abstract] [Full Text] [Related]
18. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA. Autoimmun Rev; 2016 Feb 24; 15(2):146-54. PubMed ID: 26527329 [Abstract] [Full Text] [Related]